Tuberculosis in the course of sarcoidosis treatment: is genotyping necessary for personalized therapy?

Author： Dubaniewicz Anna   Zimmermann Agnieszka   Dudziak Maria   Typiak Marlena   Skotarczak Monika  

Publisher： Informa Healthcare

ISSN： 1744-666X

Source： Expert Review of Clinical Immunology, Vol.9, Iss.4, 2013-04, pp. : 349-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the status of gene therapy for primary immunodeficiency?

By  

Immunologic Research, Vol. 38, Iss. 1-3, 2007-07 ,pp. : 274-284

Humana Press, Inc

Access to resources Recommend Favorite

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

By Sarno Maria Anna   Mancari Rosanna   Azim Hatem A   Colombo Nicoletta   Peccatori Fedro A  

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 733-741

Future Medicine

Access to resources Recommend Favorite

Treatment of autoimmune disease: time for a paradigm shift?

By Mor Felix  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 1, 2007-02 ,pp. : 13-18

Springer Publishing Company

Access to resources Recommend Favorite

Was it justified?

By Heron John  

Australasian Physical & Engineering Sciences in Medicine, Vol. 34, Iss. 1, 2011-04 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy

By Danesi R.   Mosca M.   Boggi U.   Mosca F.   Del Tacca M.  

Molecular Medicine Today, Vol. 6, Iss. 12, 2000-12 ,pp. : 475-482

Elsevier

Access to resources Recommend Favorite